Cervel Neurotech is a privately held medical device company located in San Mateo, CA. Founded in 2008, the company is pioneering an innovative, proprietary approach to non-invasive deep brain neuro-modulation using repetitive transcranial magnetic stimulation (rTMS). Cervel's technology uses magnetic fields to induce electrical currents within the brain to modulate the function of specific areas. The company's Steerable TMS technology avoids unintended stimulation of areas not associated with the disorder, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment. Cervel Neurotech's medical device is designed to provide treatment for psychiatric and neurological illnesses. The company was acquired by Rio Grande Neurosciences in 2015.